Tag Archives: drug

John Ivison: The math of saving lives — Canada’s drug battle leaves patients caught in the middle

Article content continued We feel that everyone is blaming someone else and patients are caught in the middle Vertex has done spectacularly well from Trikafta this year, reporting sales of US$ 918 million in second quarter of this year, from zero last year. That helped the company’s net income to soar 213 per cent year… Read More »

Repurposing a cancer drug to reduce COVID-19 lung inflammation

Winship Cancer Institute of Emory University (Winship) and Emory investigators are testing whether an anticancer drug can reduce lung inflammation in hospitalized COVID-19 patients, possibly preventing the need for intubation and lowering mortality. The drug is called duvelisib, and it was FDA-approved in 2018 for the treatment of relapsed or refractory chronic lymphocytic leukemia or… Read More »

Accutane Acne Drug Widely ‘Overused’ Says UK Dermatologist

By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »

Trump announces series of executive orders aimed at lowering drug costs

U.S. President Donald Trump is seated prior to signing an executive order regarding social media companies in the Oval Office of the White House in Washington, U.S., May 28, 2020. Jonathan Ernst | Reuters President Donald Trump announced Friday he will sign four executive orders aimed at lowering the high cost of prescription drugs in the… Read More »

Federal Agency Halts Studies of Hydroxychloroquine, Drug Trump Promoted

The National Institutes of Health said Saturday that it had stopped two clinical trials of hydroxychloroquine, the malaria drug that President Trump promoted to treat and prevent the coronavirus, one because the drug was unlikely to be effective and the other because not enough patients signed up to participate. The agency halted a trial that… Read More »